1887

Abstract

Epidemiological studies have shown that human papillomavirus 58 (HPV 58) is found at a relatively high frequency in east Asia and some regions of Central and South America. To investigate the physical status of HPV 58 and analyse sequence variations of HPV 58 in cervical cancer patients, the HPV 58 genome in 37 HPV 58-positive cervical cancer specimens collected from China were investigated by a mapping analysis based on nested PCR and nucleotide sequencing. A pure integrated genome was found in 78.4 % (29/37) of specimens, which is much higher than that found in previous studies. Multiple disruptions were first found among the integrated HPV 58 genomes in 51.7 % (15/29) of specimens. Among the 7824 bp of the HPV 58 genome, 119 (1.52 %) nucleotide positions were found to be variable, and 45 of them lead to amino acid changes. Phylogenetic analyses, based on partial L1 sequences of 14 variants isolated in previous studies and this study, show that two main groups were observed in HPV 58 variants, the prototype or prototype-like group and the non-prototype-like group.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.008227-0
2009-05-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/5/1229.html?itemId=/content/journal/jgv/10.1099/vir.0.008227-0&mimeType=html&fmt=ahah

References

  1. Androphy E. J., Lowy D. R., Schiller J. T. 1987; Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325:70–73 [CrossRef]
    [Google Scholar]
  2. Arias-Pulido H., Peyton C. L., Joste N. E., Vargas H., Wheeler C. M. 2006; Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44:1755–1762 [CrossRef]
    [Google Scholar]
  3. Bosch F. X., Lorincz A., Munoz N., Meijer C. J., Shah K. V. 2002; The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265 [CrossRef]
    [Google Scholar]
  4. Calleja-Macias I. E., Villa L. L., Prado J. C., Kalantari M., Allan B., Williamson A. L., Chung L. P., Collins R. J., Zuna R. E. other authors 2005; Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 79:13630–13640 [CrossRef]
    [Google Scholar]
  5. Camara G. N., Cerqueira D. M., Oliveira A. P., Silva E. O., Carvalho L. G., Martins C. R. 2003; Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 98:879–883 [CrossRef]
    [Google Scholar]
  6. Cerqueira D. M., Camara G. N. D., da Cruz M. R., Silva E. O., Brigido M. D., Carvalho L. G. D., Martins C. R. F. 2003; Variants of human papillomavirus types 53, 58 and 66 identified in Central Brazil. Virus Genes 26:83–87 [CrossRef]
    [Google Scholar]
  7. Chan P. K., Lam C. W., Cheung T. H., Li W. W., Lo K. W., Chan M. Y., Cheung J. L., Cheng A. F. 2002; Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 94:1249–1253 [CrossRef]
    [Google Scholar]
  8. Chan P. K., Cheung J. L., Cheung T. H., Lo K. W., Yim S. F., Siu S. S., Tang J. W. 2007; Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia. J Infect Dis 196:868–875 [CrossRef]
    [Google Scholar]
  9. Chan S. Y., Delius H., Halpern A. L., Bernard H. U. 1995; Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69:3074–3083
    [Google Scholar]
  10. Chen C. A., Liu C. Y., Chou H. H., Chou C. Y., Ho C. M., Twu N. F., Kan Y. Y., Chuang M. H., Chu T. Y., Hsieh C. Y. 2006; The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer 16:1801–1808 [CrossRef]
    [Google Scholar]
  11. Chen Z., Terai M., Fu L., Herrero R., DeSalle R., Burk R. D. 2005; Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 79:7014–7023 [CrossRef]
    [Google Scholar]
  12. Giannoudis A., Herrington C. S. 2001; Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193:295–302 [CrossRef]
    [Google Scholar]
  13. Gonzalez-Losa Mdel R., Rosado-Lopez I., Valdez-Gonzalez N., Puerto-Solis M. 2004; High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol 29:202–205
    [Google Scholar]
  14. Hegde R. S., Grossman S. R., Laimins L. A., Sigler P. B. 1992; Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359:505–512 [CrossRef]
    [Google Scholar]
  15. Hildesheim A., Schiffman M., Bromley C., Wacholder S., Herrero R., Rodriguez A., Bratti M. C., Sherman M. E., Scarpidis U. other authors 2001; Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315–318 [CrossRef]
    [Google Scholar]
  16. Ho C. M., Chien T. Y., Huang S. H., Lee B. H., Chang S. F. 2006; Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 102:54–60 [CrossRef]
    [Google Scholar]
  17. Huang S., Afonina I., Miller B. A., Beckmann A. M. 1997; Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70:408–411 [CrossRef]
    [Google Scholar]
  18. Jeon S., Lambert P. F. 1995; Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92:1654–1658 [CrossRef]
    [Google Scholar]
  19. Kjaer S. K., van den Brule A. J., Bock J. E., Poll P. A., Engholm G., Sherman M. E., Walboomers J. M., Meijer C. J. 1996; Human papillomavirus – the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65:601–606 [CrossRef]
    [Google Scholar]
  20. Kurvinen K., Yliskoski M., Saarikoski S., Syrjanen K., Syrjanen S. 2000; Variants of the long control region of human papillomavirus type 16. Eur J Cancer 36:1402–1410 [CrossRef]
    [Google Scholar]
  21. Lewis H., Webster K., Sanchez-Perez A. M., Gaston K. 1999; Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein. J Gen Virol 80:2087–2096
    [Google Scholar]
  22. Lizano M., Berumen J., Guido M. C., Casas L., Garcia-Carranca A. 1997; Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89:1227–1231 [CrossRef]
    [Google Scholar]
  23. Matsumoto K., Yoshikawa H., Nakagawa S., Tang X., Yasugi T., Kawana K., Sekiya S., Hirai Y., Kukimoto I. other authors 2000; Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156:159–165 [CrossRef]
    [Google Scholar]
  24. Munoz N. 2000; Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5 [CrossRef]
    [Google Scholar]
  25. Munoz N., Bosch F. X., de Sanjose S., Herrero R., Castellsague X., Shah K. V., Snijders P. J., Meijer C. J. 2003; Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527 [CrossRef]
    [Google Scholar]
  26. Qiu A. D., Wu E. Q., Yu X. H., Jiang C. L., Jin Y. H., Wu Y. G., Chen Y., Chen Y., Shan Y. M. other authors 2007; HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol 104:77–85 [CrossRef]
    [Google Scholar]
  27. Romanczuk H., Thierry F., Howley P. M. 1990; Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 64:2849–2859
    [Google Scholar]
  28. Stephen A. L., Thompson C. H., Tattersall M. H., Cossart Y. E., Rose B. R. 2000; Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 86:695–701 [CrossRef]
    [Google Scholar]
  29. Stewart A. C., Eriksson A. M., Manos M. M., Munoz N., Bosch F. X., Peto J., Wheeler C. M. 1996; Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol 70:3127–3136
    [Google Scholar]
  30. Storey A., Piccini A., Massimi P., Bouvard V., Banks L. 1995; Mutations in the human papillomavirus type 16 E2 protein identify a region of the protein involved in binding to E1 protein. J Gen Virol 76:819–826 [CrossRef]
    [Google Scholar]
  31. Thierry F., Howley P. M. 1991; Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol 3:90–100
    [Google Scholar]
  32. Tornesello M. L., Duraturo M. L., Buonaguro L., Vallefuoco G., Piccoli R., Palmieri S., Buonaguro F. M. 2007; Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2, 1 [CrossRef]
    [Google Scholar]
  33. Villa L. L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., Franco E. L. 2000; Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959–2968
    [Google Scholar]
  34. Wheeler C. M., Yamada T., Hildesheim A., Jenison S. A. 1997; Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35:11–19
    [Google Scholar]
  35. Xin C. Y., Matsumoto K., Yoshikawa H., Yasugi T., Onda T., Nakagawa S., Yamada M., Nozawa S., Sekiya S. other authors 2001; Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 170:19–24 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.008227-0
Loading
/content/journal/jgv/10.1099/vir.0.008227-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error